Hydroxytyrosol and Potential Uses in Cardiovascular Diseases, Cancer, and AIDS

Frontiers in Nutrition

Volumn 1, Issue , 2014, Pages

  Vilaplana Pérez, Cristina ^a   Auñón, David ^b   García Flores, Libia A ^a   Gil Izquierdo, Angel ^a  

^a RESEARCH GROUP ON QUALITY   (Spain)

^b SL ^*  (Spain)

Author keywords

anti oxidants; disease; hydroxytyrosol; olive oil; phenolic compounds

Indexed keywords

EID: 84964573998     PISSN: None     EISSN: 2296861X     Source Type: Journal    
DOI: 10.3389/fnut.2014.00018     Document Type: Review

References (123)

1. Genevieve Buckland CAG. Trends in olive production, supply and consumption in Mediterranean countries from 1961 to the present day. In: Inc E, editor. Olives and Olive Oil in Health and Disease Prevention (2010). p. 689–98.
2. Kromhout D, Keys A, Aravanis C, Buzina R, Fidanza F, Giampaoli S, et al. Food consumption patterns in the 1960s in seven countries. Am J Clin Nutr (1989) 49:889–94.
3. FDA Allows Qualified Health Claim to Decrease Risk of Coronary Heart Disease. FDA News Release (2004). Available from: http://www.fda.gov/newsevents/newsroom/pressannouncements/2004/ucm108368.htm
4. Boskou D. Olive Oil. Chemistry and Technology. Second ed. Champaign, IL: AOCS Press (2006).
5. Soler-Rivas C, Espin JC, Wichers HJ. Oleuropein and related compounds. J Sci Food Agric (2000) 80(7):1013–23.10.1002/(SICI)1097-0010(20000515)80:7<1013::AID-JSFA571>3.0.CO;2-C
6. Owen RW, Mier W, Giacosa A, Hull WE, Spiegelhalder B, Bartsch H. Phenolic compounds and squalene in olive oils: the concentration and antioxidant potential of total phenols, simple phenols, secoiridoids, lignans and squalene. Food Chem Toxicol (2000) 38(8):647–59.10.1016/S0278-6915(00)00061-210908812
7. Romero C, Brenes M, Yousfi K, García P, García A, Garrido A. Effect of cultivar and processing method on the contents of polyphenols in table olives. J Agric Food Chem (2004) 52:479–84.10.1021/jf030525l14759136
8. Visioli F, Bellomo G, Galli C. Free radical-scavenging properties of olive oil polyphenols. Biochem Biophys Res Commun (1998) 247(1):60–4.10.1006/bbrc.1998.87359636654
9. Visioli F, Galli C, Bornet F, Mattei A, Patelli R, Galli G, et al. Olive oil phenolics are dose-dependently absorbed in humans. FEBS Lett (2000) 468(2–3):159–60.10.1016/S0014-5793(00)01216-310692578
10. Boskou D. Olive Oil: Minor Constituents and Health. Boca Raton, FL: CRC Press (2008).
11. Esti M, Cinquanta L, La Notte E. Phenolic compounds in different olive varieties. J Agric Food Chem (1998) 46(1):32–5.10.1021/jf970391+10554192
12. Charoenprasert S, Mitchell A. Factors influencing phenolic compounds in table olives (Olea europaea). J Agric Food Chem (2012) 60:7081–95.10.1021/jf301769922720792
13. Owen RW, Haubner R, Mier W, Giacosa A, Hull WE, Spiegelhalder B, et al. Isolation, structure elucidation and antioxidant potential of the major phenolic and flavonoid compounds in brined olive drupes. Food Chem Toxicol (2003) 41:703–17.10.1016/S0278-6915(03)00011-512659724
14. Dimitrios B. Sources of natural phenolic antioxidants. Trends Food Sci Technol (2006) 17(9):505–12.10.1016/j.tifs.2006.04.004
15. Fernandez-Bolaños J, Heredia A, Felizon B, Brenes M, Guillen R, Rodriguez R. Procedimiento de obtencion de hidroxitirosol a partir de hueso de aceituna. ES 2145701 B1 (2001).
16. Fernández-Mar MI, Mateos R, García-Parrilla MC, Puertas B, Cantos-Villar E. Bioactive compounds in wine: resveratrol, hydroxytyrosol and melatonin: a review. Food Chem (2012) 130(4):797–813.10.1016/j.foodchem.2011.08.023
17. de la Torre R, Covas M, Pujadas M, Fitó M, Farré M. Is dopamine behind the health benefits of red wine? Eur J Nutr (2006) 45(5):307–10.10.1007/s00394-006-0596-916586149
18. Bai C, Yan X, Takenaka M, Sekiya K, Nagata T. Determination of synthetic hydroxytyrosol in rat plasma by GC-MS. J Agric Food Chem (1998) 46(10):3998–4001.10.1021/jf980451r
19. Tuck KL, Freeman MP, Hayball PJ, Stretch GL, Stupans I. The in vivo fate of hydroxytyrosol and tyrosol, antioxidant phenolic constituents of olive oil, after intravenous and oral dosing of labeled compounds to rats. J Nutr (2001) 131(7):1993–6.11435519
20. Miro-Casas E, Covas MI, Fito M, Farre-Albadalejo M, Marrugat J, de la Torre R. Tyrosol and hydroxytyrosol are absorbed from moderate and sustained doses of virgin olive oil in humans. Eur J Clin Nutr (2003) 57(1):186–90.10.1038/sj.ejcn.160153212548315
21. Visioli F, Galli C, Grande S, Colonnelli K, Patelli C, Galli G, et al. Hydroxytyrosol excretion differs between rats and humans and depends on the vehicle of administration. J Nutr (2003) 133(8):2612–5.12888646
22. De la Torre R. Bioavailability of olive oil phenolic compounds in humans. Inflammopharmacology (2008) 16:245–7.10.1007/s10787-008-8029-418815736
23. Vissers MN, Zock PL, Roodenburg AJC, Leenen R, Katan MB. Olive oil phenols are absorbed in humans. J Nutr (2002) 132:409–17.11880564
24. Miro-Casas E, Covas MI, Farre M, Fito M, Ortuño J, Weinbrenner T, et al. Hydroxytyrosol disposition in humans. Clin Chem (2003) 49(6):945–52.10.1373/49.6.945
25. Tuck KL, Hayball PJ, Stupans I. Structural characterization of the metabolites of hydroxytyrosol, the principal phenolic component in olive oil, in rats. J Agric Food Chem (2002) 50(8):2404–9.10.1021/jf011264n11929304
26. Khymenets O, Fitó M, Touriño S, Muñoz-Aguayo D, Pujadas M, Torres JL, et al. Antioxidant activities of hydroxytyrosol main metabolites do not contribute to beneficial health effects after olive oil ingestion. Drug Metab Dispos (2010) 38(9):1417–21.10.1124/dmd.110.03282120516254
27. Prior RR, Wu X, Schaich K. Standardized methods for the determination of antioxidant capacity and phenolics in foods and dietary supplements. J Agric Food Chem (2005) 53:4290–302.10.1021/jf050269815884874
28. Khurana S, Venkataraman K, Hollingworth A, Piche M, Tai TC. Polyphenols: benefits to the cardiovascular system in health and in aging. Nutrients (2013) 5:3779–827.10.3390/nu510377924077237
29. Cicerale S, Lucas L, Keast R. Biological activities of phenolic compounds present in virgin olive oil. Int J Mol Sci (2010) 11:458–79.10.3390/ijms1102045820386648
30. Bulotta S, Celano M, Lepore SM, Montalcini T, Pujia A, Russo D. Beneficial effects of the olive oil phenolic components oleuropein and hydroxytyrosol: focus on protection against cardiovascular and metabolic diseases. J Transl Med (2014) 12(1):219.10.1186/s12967-014-0219-925086598
31. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens (2000) 18(6):655–73.10.1097/00004872-200018060-00002
32. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest (1991) 88:1785–92.10.1172/JCI1154991752940
33. De Nigris F, Lerman LO, Condorelli M, Lerman A, Napoli C. Oxidation-sensitive transcription factors and molecular mechanisms in the arterial wall. Antioxid Redox Signal (2001) 3(6):1119–30.10.1089/15230860131720362011813985
34. Spagnoli LG, Bonanno E, Sangiorgi G, Mauriello A. Role of inflammation in atherosclerosis. J Nucl Med (2007) 48(11):1800–15.10.2967/jnumed.107.038661
35. ’t Hoen PAC, Van der Lans CAC, Van Eck M, Bijsterbosch MK, Van Berkel TJC, Twisk J. Aorta of ApoE-deficient mice responds to atherogenic stimuli by a prelesional increase and ubsequent decrease in the expression of antioxidant enzymes. Circulation Research (2003) 93:262–9.
36. Zrelli H, Mieko Matsuoka M, Kitazaki S, Zarrouk M, Miyazaki H. Hydroxytyrosol reduces intracellular reactive oxygen species levels in vascular endothelial cells by upregulating catalase expression through the AMPK-FOXO3a pathway. Eur J Pharmacol (2011) 660:275–82.10.1016/j.ejphar.2011.03.04521497591
37. Gonzalez-Santiago M, Martín-Bautista E, Carrero JJ, Fonollá J, Baró L, Bartolomé MV, et al. One-month administration of hydroxytyrosol, a phenolic antioxidant present in olive oil, to hyperlipidemic rabbits improves blood lipid profile, antioxidant status and reduces atherosclerosis development. Atheroslerosis (2006) 188:35–42.10.1016/j.atherosclerosis.2005.10.022
38. Carluccio MA, Siculella L, Ancora MA, Massaro M, Scoditti E, Storelli C, et al. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation. Antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol (2003) 23:622–9.10.1161/01.ATV.0000062884.69432.A012615669
39. Visioli F, Bellomo G, Montedoro G, Galli C. Low density lipoprotein oxidation is inhibited in vitro by olive oil constituents. Atherosclerosis (1995) 117(1):25–32.10.1016/0021-9150(95)05546-98546752
40. Castañer O, Covas MI, Khymenets O, Nyyssonen K, Konstantinidou V, Zunft HF, et al. Protection of LDL from oxidation by olive oil polyphenols is associated with a downregulation of CD40-ligand expression and its downstream products in vivo in humans. Am J Clin Nutr (2012) 95(5):1238–44.10.3945/ajcn.111.02920722440854
41. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific opinion on the substantiation of health claims related to polyphenols in olive and protection of LDL particles from oxidative damage (ID 1333, 1638, 1639, 1696, 2865), maintenance of normal blood HDL-cholesterol concentrations (ID 1639), maintenance of normal blood pressure (ID 3781), “anti-inflammatory properties” (ID 1882), “contributes to the upper respiratory tract health” (ID 3468), “can help to maintain a normal function of gastrointestinal tract” (3779), and “contributes to body defences against external agents” (ID 3467) pursuant to Article 13(1) of Regulation (EC) No 1924/20061. EFSA J (2011) 9(4):2033.10.2903/j.efsa.2011.2033
42. Fitó M, Covas MI, Lamuela-Raventós RM, Vila J, de la Torre C, Marrugat J. Aceite de oliva e inhibición de la oxidación de las lipoproteínas de baja densidad. Importancia de los compuestos fenólicos. Med Clín (2000) 115(5):166–9.10.1016/S0025-7753(00)71497-710996871
43. Gimeno E, Fitó M, Lamuela-Raventós RM, Castellote AI, Covas M, Farré M, et al. Effect of ingestion of virgin olive oil on human low-density lipoprotein composition. Eur J Clin Nutr (2002) 56(2):114–20.10.1038/sj.ejcn.160129311857044
44. Marrugat J, Covas MI, Fitó M, Schröder H, Miró-Casas E, Gimeno E, et al. Effects of differing phenolic content in dietary olive oil on lipids and LDL oxidation: a randomized controlled trial. Eur J Nutr (2004) 43(3):140–7.10.1007/s00394-004-0452-815168036
45. Weinbrenner T, Fitó M, Farré-Albadalejo M, Saez GT, Rijken P, Tormos C, et al. Bioavailability of phenolic compounds from olive oil and oxidative/antioxidant status at postprandial state in healthy humans. Drugs Exp Clin Res (2004) 30:207–12.15700748
46. Covas MI, de la Torre K, Farré-Albaladejo M, Kaikkonen J, Fitó M, López-Sabater C, et al. Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans. Free Radic Biol Med (2006) 40(4):608–16.10.1016/j.freeradbiomed.2005.09.02716458191
47. Covas MI, Nyyssönen K, Poulsen HE, Kaikkonen J, Zunft HJF, Kiesewetter H, et al. The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Ann Intern Med (2006) 145(5):333–41.10.7326/0003-4819-145-5-200609050-0000616954359
48. de la Torre-Carbot K, Chávez-Servín JL, Jaúregui O, Castellote AI, Lamuela-Raventós RM, Nurmi T, et al. Elevated circulating LDL phenol levels in men who consumed virgin rather than refined olive oil are associated with less oxidation of plasma LDL. J Nutr (2010) 140(3):501–8.10.3945/jn.109.11291220089783
49. Libby P, Paul M, RidkerP M, Hansson GK. Progress and challenges in translating the biology of aterosclerosis. Nature (2011) 473:317–25.10.1038/nature1014621593864
50. Dell’Agli M, Mashi O, Galli GV, Fagnani R, Dal Cero E, Caruso D, et al. Inhibition of platelet aggregation by olive oil phenols via cAMP-phosphodiesterase. Br J Nutr (2008) 99(5):945–51.10.1017/S000711450783747017927845
51. Petroni A, Blasevich M, Salami M, Papini N, Montedoro GF, Galli C. Inhibition of platelet aggregation and eicosanoid production by phenolic components of olive oil. Thromb Res (1995) 78(2):151–60.10.1016/0049-3848(95)00043-77482432
52. Léger CL, Carbonneau MA, Michel F, Mas E, Monnier L, Cristol JP, et al. A thromboxane effect of a hydroxytyrosol-rich oliveoil wastewater extract in patients with uncomplicated type I diabetes. Eur J Clin Nutr (2005) 59:727–30.10.1038/sj.ejcn.160213315798774
53. Visioli F, Caruso D, Grande S, Bosisio R, Villa M, Galli G, et al. Virgin Olive Oil Study (VOLOS): vasoprotective potential of extra virgin olive oil in mildly dyslipidemic patients. Eur J Nutr (2005) 44:121–7.10.1007/s00394-004-0504-015309433
54. González-Correa JA, Navas MD, Muñoz-Marín J, Trujillo M, Fernández-Bolaños J, De La Cruz JP. Effects of hydroxytyrosol and hydroxytyrosol acetate administration to rats on platelet function compared to acetylsalicylic acid. J Agric Food Chem (2008) 56:7872–6.10.1021/jf801502z18707113
55. Procopio A, Alcaro S, Nardi M, Oliverio M, Ortuso F, Sacchetta P, et al. Synthesis, biological evaluation and molecular modelling of oleuropein and its semisynthetic derivatives as cyclooxygenase inhibitors. J Agric Food Chem (2009) 57:11161–7.10.1021/jf903330519908866
56. Zhang X, Cao J, Jiang L, Zhong L. Suppressive effects of hydroxytyrosol on oxidative stress and nuclear factor-kappaB activation in THP-1 cells. Biol Pharm Bull (2009) 32:578–82.10.1248/bpb.32.57819336887
57. Fitó M, Cladellas M, de la Torre R, Martí J, Muñoz D, Schröder H, et al. Anti-inflammatory effect of virgin olive oil in stable coronary disease patients: a randomized, crossover, controlled trial. Eur J Clin Nutr (2008) 62(4):570–4.10.1038/sj.ejcn.160272417375118
58. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GDO, Fowkes FGR. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population. Circulation (2005) 112:976–83.10.1161/CIRCULATIONAHA.104.51308516087797
59. Richard N, Arnold S, Hoeller U, Kilpert C, Wertz K, Schwager J. Hydroxytyrosol is the major anti-inflammatory compound in aqueous olive extracts and impairs cytokine and chemokine production in macrophages. Planta Med (2011) 77(17):1890–7.10.1055/s-0031-128002221830187
60. Killeen MJ, Linder M, Pontoniere P, Crea R. NF-kb signaling and chronic inflammatory diseases: exploring the potential of natural products to drive new therapeutic opportunities. Drug Discov Today (2014) 19(4):373–8.10.1016/j.drudis.2013.11.00224246683
61. Umar A, Dunn BK, Greenwald P. Future directions in cancer prevention. Nat Rev Cancer (2012) 12(12):835–48.10.1038/nrc3397
62. Vauzour D, Rodriguez-Mateos A, Corona G, Oruna-Concha MJ, Spencer JP. Polyphenols and human health: prevention of disease and mechanisms of action. Nutrients (2010) 2:1106–31.10.3390/nu211110622254000
63. Psaltopoulou T, Kosti RI, Haidopoulos D, Dimopoulos M, Panagiotakos DB. Olive oil intake is inversely related to cancer prevalence: a systematic review and a meta-analysis of 13,800 patients and 23,340 controls in 19 observational studies. Lipids Health Dis (2011) 10:127.10.1186/1476-511X-10-12721801436
64. Steward WP, Brown K. Cancer chemoprevention: a rapidly evolving field. Br J Cancer (2013) 109(1):1–7.10.1038/bjc.2013.280
65. Tsao AS, Kim ES, Hong WK. Chemoprevention of cancer. CA Cancer J Clin (2004) 54(3):150–80.
66. Priyadarsini RV, Nagini S. Cancer chemoprevention by dietary phytochemicals: promises and pitfalls. Curr Pharm Biotechnol (2012) 13(1):125–36.10.2174/13892011279886861021466433
67. Filik L, Ozyilkan O. Olive-oil consumption and cancer risk. Eur J Clin Nutr (2003) 57:191.10.1038/sj.ejcn.1601497
68. Visioli F. Olive oil phenolics: where do we stand? Where should we go? J Sci Food Agric (2012) 92:2017–9.10.1002/jsfa.571522549365
69. Frankel EN. Nutritional and biological properties of extra virgin olive oil. J Agric Food Chem (2011) 59(3):785–92.10.1021/jf103813t21210703
70. Granados-Principal S, Quiles JL, Ramirez-Tortosa CL, Sanchez-Rovira P, Ramirez-Tortosa MC. Hydroxytyrosol: from laboratory investigations to future clinical trials. Nutr Rev (2010) 68(4):191–206.10.1111/j.1753-4887.2010.00278.x20416016
71. Quirantes-Piné R, Zurek G, Barrajón-Catalán E, Bäßmann C, Micol V, Segura-Carretero A, et al. A metabolite-profiling approach to assess the uptake and metabolism of phenolic compounds from olive leaves in SKBR3 cells by HPLC–ESI-QTOF-MS. J Pharm Biomed Anal (2013) 72(0):121–6.10.1016/j.jpba.2012.09.02923146235
72. TM) in HER-overexpressing breast cancer cells. BMC Cancer (2007) 7:80.10.1186/1471-2407-7-8017490486
73. Fabiani R, Rosignoli P, De Bartolomeo A, Fuccelli R, Servili M, Montedoro GF, et al. Oxidative DNA damage is prevented by extracts of olive oil, hydroxytyrosol, and other olive phenolic compounds in human blood mononuclear cells and HL60 cells. J Nutr (2008) 138(8):1411–6.18641183
74. Fabiani RDBA, Rosignoli P, Servili M, Montedoro GF, Morozzi G. Cancer chemoprevention by hydroxytyrosol isolated from virgin olive oil through G1 cell cycle arrest and apoptosis. Eur J Cancer Prev (2002) 11(4):351–8.10.1097/00008469-200208000-0000612195161
75. Ramos S. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol Nutr Food Res (2008) 52(5):507–26.10.1002/mnfr.20070032618435439
76. Halliwell B. Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? Arch Biochem Biophys (2008) 476:107–12.10.1016/j.abb.2008.01.02818284912
77. Hua Long L, Hoi A, Halliwell B. Instability of, and generation of hydrogen peroxide by, phenolic compounds in cell culture media. Arch Biochem Biophys (2010) 501(1):162–9.10.1016/j.abb.2010.06.01220558131
78. Odiatou EM, Skaltsounis AL, Constantinou AI. Identification of the factors responsible for the in vitro pro-oxidant and cytotoxic activities of the olive polyphenols oleuropein and hydroxytyrosol. Cancer Lett (2013) 330:113–21.10.1016/j.canlet.2012.11.03523201137
79. Babich H, Schuck AG, Weisburg JH, Zuckerbraun HL. Research strategies in the study of the pro-oxidant nature of polyphenol nutraceuticals. J Toxicol (2011) 2011:467305.10.1155/2011/46730521776260
80. Fabiani R, Sepporta MV, Rosignolli P, De Bartolomeo A, Crescimanno M, Morozzi G. Anti-proliferative and pro-apoptotic activities of hydroxytyrosol on different tumour cells: the role of extracellular production of hydrogen peroxide. Eur J Nutr (2012) 51:455–64.10.1007/s00394-011-0230-321805082
81. Veal EA, Day AM, Morgan BA. Hydrogen peroxide sensing and signaling. Mol Cell (2007) 26(1):1–14.10.1016/j.molcel.2007.03.016
82. Fabiani R, Sepporta MV, Mazza T, Rosignoli P, Fuccelli R, De Bartolomeo A, et al. Influence of cultivar and concentration of selected phenolic constituents on the in vitro chemiopreventive potential of olive oil extracts. J Agric Food Chem (2011) 59:8167–74.10.1021/jf201459u21702505
83. Ragione FD, Cucciolla V, Borriello A, Pietra VD, Pontoni G, Racioppi L, et al. Hydroxytyrosol, a natural molecule occurring in olive oil, induces cytochrome c-dependent apoptosis. Biochem Biophys Res Commun (2000) 278(3):733–9.10.1006/bbrc.2000.387511095977
84. Fulvio DR, Cucciolla V, Criniti V, Indaco S, Borriello A, Zappia V. Antioxidants induce different phenotypes by a distinct modulation of signal transduction. FEBS Lett (2002) 532:289–94.10.1016/S0014-5793(02)03683-912482581
85. Kip1 and with induction of differentiation in HL60 Cells. J Nutr (2008) 138:42–8.18156402
86. Guichard C, Pedruzzi E, Fay M, Marie JC, Braut-Boucher F, Daniel F, et al. Dihydroxyphenylethanol induces apoptosis by activating serine/threonine protein phosphatase PP2A and promotes the endoplasmic reticulum stress response in human colon carcinoma cells. Carcinogenesis (2006) 27(9):1812–27.10.1093/carcin/bgl00916524888
87. Corona G, Deiana M, Incani A, Vauzour D, Dessí MA, Spencer JPE. Hydroxytyrosol inhibits the proliferation of human colon adenocarcinoma cells through inhibition of ERK1/2 and cyclin D1. Mol Nutr Food Res (2009) 53(7):897–903.10.1002/mnfr.20080026919685549
88. Corona G, Deiana M, Incani A, Vanzour D, Dessi MA, Spencer JPE. Inhibition of p38/CREB phosphorylation and COX-2 expression by olive oil polyphenols underlies their anti-proliferative effects. Biochem Biophys Res Commun (2007) 362:606–11.10.1016/j.bbrc.2007.08.04917727817
89. Pereira-Caro G, Mateos R, Traka MH, Bacon JR, Bongaerts R, Sarriá B, et al. Hydroxytyrosyl ethyl ether exhibits stronger intestinal anticarcinogenic potency and effects on transcript profiles compared to hydroxytyrosol. Food Chem (2013) 138:1172–82.10.1016/j.foodchem.2012.11.11823411228
90. Notarnicola M, Pisanti S, Tutino V, Bocale D, Rotelli MT, Gentile A, et al. Effects of olive oil polyphenols on fatty acid synthase gene expression and activity in human colorectal cancer cells. Genes Nutr (2011) 6(1):63–9.10.1007/s12263-010-0177-721437031
91. Yumi ZH-Y, Hashim IRR, McGlynn H, Servili M, Selvaggini R, Taticchi A-SE, et al. Inhibitory effects of olive oil phenolics on invasion in human colon adenocarcinoma cells in vitro. Int J Cancer (2008) 122(3):495–500.10.1002/ijc.2314817943720
92. Bouallagui Z, Han J, Isoda H, Sayadi S. Hydroxytyrosol rich extract from olive leaves modulates cell cycle progression in MCF-7 human breast cancer cells. Food Chem Toxicol (2011) 49(1):179–84.10.1016/j.fct.2010.10.01420955751
93. Han J, Talorete TP, Yamada P, Isoda H. Anti-proliferative and apoptotic effects of oleuropein and hydroxytyrosol on human breast cancer MCF-7 cells. Cytotechnology (2009) 59:45–53.10.1007/s10616-009-9191-219353300
94. Sirianni R, Chimento A, De Luca A, Casaburi I, Rizza P, Onofrio A, et al. Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation. Mol Nutr Food Res (2010) 54:833–40.10.1002/mnfr.20090011120013881
95. Elamin MH, Hassan ZK, Omer SA, Daghestani MH, Al-Olayan EM, Virk P, et al. Apoptotic and antiproliferative activity of olive oil hydroxytyrosol on breast cancer cells. J Med Plants Res (2013) 7(32):2420–8.10.5897/JMPR12.1321
96. Sarsour EH, Goswami M, Kalen AL, Lafin JT, Goswami PC. Hydroxytyrosol inhibits chemokine C-C motif ligand 5 mediated aged quiescent fibroblast-induced stimulation of breast cancer cell proliferation. Age (2014) 36(3):9645.10.1007/s11357-014-9645-024691968
97. Zhao B, Ma Y, Xu Z, Wang J, Wang F, Wang D, et al. Hydroxytyrosol, a natural molecule from olive oil, suppresses the growth of human hepatocellular carcinoma cells via inactivating AKT and nuclear factor-kappa B pathways. Cancer Lett (2014) 347(1):79–87.10.1016/j.canlet.2014.01.02824486741
98. Pereira Caro G, Mateos R, Sarria B, Cert R, Goya L, Bravo L. Hydroxytyrosol acetate contributes to the protective effects against oxidative stress of virgin olive oil. Food Chem (2012) 131(3):86978.10.1016/j.foodchem.2011.09.068
99. Li S, Han Z, Ma Y, Song R, Pei T, Zheng T, et al. Hydroxytyrosol inhibits cholangiocarcinoma tumor growth: an in vivo and in vitro study. Oncol Rep (2014) 31(1):145–52.10.3892/or.2013.285324247752
100. Sepporta MV, López-García MÁ, Fabiani R, Maya I, Fernández-Bolaños JG. Enhanced chemopreventive activity of hydroxytyrosol on HL60 and HL60R cells by chemical conversion into thio derivatives. Eur J Pharm Sci (2013) 48(4–5):790–8.10.1016/j.ejps.2012.12.02823313620
101. Kang NJ, Shin SH, Lee HJ, Lee KW. Polyphenols as small molecular inhibitors of signaling cascades in carcinogenesis. Pharmacol Ther (2011) 130(3):310–24.10.1016/j.pharmthera.2011.02.00421356239
102. Capasso G, Di Gennaro CI, Della Ragione F, Manna C, Ciarcia R, Florio S, et al. In vivo effect of the natural antioxidant hydroxytyrosol on cyclosporine nephrotoxicity in rats. Nephrol Dial Transplant (2008) 23(4):1186–95.10.1093/ndt/gfm78418057067
103. Granados-Principal S, Quiles JL, Ramirez-Tortosa C, Camacho-Corencia P, Sanchez-Rovira P, Vera-Ramirez L, et al. Hydroxytyrosol inhibits growth and cell proliferation and promotes high expression of sfrp4 in rat mammary tumours. Mol Nutr Food Res (2011) 55(Suppl 1):S117–26.10.1002/mnfr.20100022021120994
104. Bernini R, Merendino N, Romani A, Velotti F. Naturally occurring hydroxytyrosol: synthesis and anticancer potential. Curr Med Chem (2013) 20(5):655–70.10.2174/09298671380499936723244583
105. Rafehi H, Smith AJ, Balcerczyk A, Ziemann M, Ooi J, Loveridge SJ, et al. Investigation into the biological properties of the olive polyphenol, hydroxytyrosol: mechanistic insights by genome-wide mRNA-Seq analysis. Genes Nutr (2012) 7(2):343–55.10.1007/s12263-011-0249-321953375
106. Emília Juan M, Uwe W, Hannelore D, Joana MP. Olives and olive oil in health and disease prevention. Cancer Chemopreventive Activity of Hydroxytyrosol: A Natural Antioxidant from Olives and Olive Oil. London: Elsevier (2010). p. 1295–300.
107. Hsiao AF, Wong MD, Kanouse DE, Collins RL, Liu H, Andersen RM, et al. HCSUS Consortium. Complementary and alternative medicine use and substitution for conventional therapy by HIV-infected patients. J Adquir Immune Defic Syndr (2003) 33(2):157–65.10.1097/00126334-200306010-0000712794548
108. Wright SC, Maree JE, Sibanyoni M. Treatment of oral thrush in HIV/AIDS patients with lemon juice and lemon grass (Cymbopogon citratus) and gentian violet. Phytomedicine (2009) 16(2–3):118–24.10.1016/j.phymed.2008.07.01519109001
109. Zou W, Liu Y, Wang J, Li H, Liao X. Traditional chinese herbal medicines for treating HIV infections and AIDS. Evid Based Complement Alternat Med (2012) 2012:950757.10.1155/2012/95075723326295
110. Lee-Huang S, Zhang L, Huang PL, Chang YT. Anti-HIV activity of olive leaf extract (OLE) and modulation of host cell gene expression by HIV-1 infection and OLE treatment. Biochem Biophys Res Commun (2003) 307(4):1029–37.10.1016/S0006-291X(03)01292-0
111. Lee-Huang S, Huang PL, Zhang D, Lee JW, Bao J, Sun Y, et al. Discovery of small-molecule HIV-1 fusion and integrase inhibitors oleuropein and hydroxytyrosol: Part I. Integrase inhibition. Biochem Biophys Res Commun (2007) 354(4):872–8.10.1016/j.bbrc.2007.01.071
112. Lee-Huang S, Huang PL, Zhang D, Lee JW, Bao J, Sun Y, et al. Discovery of small-molecule HIV-1 fusion and integrase inhibitors oleuropein and hydroxytyrosol: Part II. Integrase inhibition. Biochem Biophys Res Commun (2007) 354(4):879–84.10.1016/j.bbrc.2007.01.05817261269
113. Crea R. Method and Composition for Treatment of Inflamation and AIDS-Associated Neurological Disorders. US 0039066 A1 (2004).
114. Gómez-Acebo E, Alcamí Pertejo J, Auñón-Calles D. Topical Use of Hydroxytyrosol and Derivatives for the Prevention of HIV Infection. WO 067302 A1 (2011).
115. Vissers MN, Zock PL, Katan MB. Bioavailability and antioxidant effects of olive oil phenols in humans: a review. Eur J Clin Nutr (2004) 58(6):955–65.10.1038/sj.ejcn.160191715164117
116. De la Torre-Robles A, Rivas A, Lorenzo-Tovar ML, Monteagudo C, Mariscal-Arcas M, Olea-Serrano F. Estimation of the intake of phenol compounds from virgin olive oil of a population from southern Spain. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2014).10.1080/19440049.2014.93596124945796
117. Giordano E, Dávalos A, Visioli F. Chronic hydroxytyrosol feeding modulates glutation-mediated oxido-reduction pathways in adipose tissue: a nutrigenomic study. Nutr, Metab Cardiovasc Dis (2014) 24(10):1144–50.10.1016/j.numecd.2014.05.00324984826
118. Giordano E, Dávalos A, Nicod N, Visioli F. Hydroxytyrosol attenuates tunicamycin-induced endoplasmic reticulum stress in human hepatocarcinoma cells. Mol Nutr Food Res (2014) 58:954–62.10.1002/mnfr.20130046524347345
119. Visioli F, Wolfram R, Richard D, Abdullah MICB, Crea R. Olive phenolics increase glutathione levels in healthy volunteers. J Agric Food Chem (2009) 57:1793–6.10.1021/jf803442919219997
120. D’Angelo S, Manna C, Migliardi V, Mazzoni O, Morrica P, Capasso G, et al. Pharmacokinetics and metabolism of hydroxytyrosol, a natural antioxidant from olive oil. Drug Metab Dispos (2001) 29(11):1492–8.
121. Christian MS, Sharper VA, Hoberman AM, Seng JE, Fu L, Covell D, et al. The toxicity profile of hydrolyzed aqueous olive pulp extract. Drug Chem Toxicol (2004) 27(4):309–30.10.1081/DCT-20003971415573469
122. Auñon-Calles D, Canut L, Visioli F. Toxicological evaluation of pure hydroxytyrosol. Food Chem Toxicol (2013) 55(0):498–504.10.1016/j.fct.2013.01.03023380205
123. The AIM-HIV Project. Available from: http://aim-hiv.isciii.es/